KJAER, TANJA MARIA ROSENKILDE,KRUSE, THOMAS,MYGIND, PER HOLSE,BRINCH, KAROLINE SIDELMANN,KJAERULFF, SOEREN,ANDERSEN, BIRGITTE
申请号：
NZ59046609
公开号：
NZ590466A
申请日:
2009.07.17
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Use of a human beta defensin having at least 80% identity to the amino acid sequences of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO:4 in the manufacture of a medicament for the treatment of an inflammatory disease or disorder selected from the group consisting of osteoarthritis, multiple sclerosis, artherosclerosis, scleroderma (systemic sclerosis), lupus, systemic lupus erythematosus (SLE), (acute) glomerulonephritis, asthma, chronic obstructive pulmonary diseases (COPD), respiratory distress-syndrome (ARDS), vasculitis, uveitis, dermatitis, atopic dermatitis, alopecia, rhinitis (allergica), allergic conjunctivitis, myasthenia gravis, sclerodermitis, sarcoidosis, psoriatic arthritis, psoriasis, ankylosing spondylitis, juvenile idiopathic arthritis,Graves disease, Sjogrens syndrome, and Behçet disease.
